“We are very proud of the extraordinary team effort by Elekta, Philips and the MR-linac Consortium members that was necessary to obtain the CE mark for Unity,” said Rob Cascella, Chief Business Leader of the Diagnosis and Treatment businesses at Royal Philips. “With this significant milestone, we believe the expanded use of MR imaging in oncology, from diagnosis and therapy planning to image-guided treatment, will improve outcomes and enhance overall patient care.”
Philips’ Ingenia MR-RT simulation platform with MR linac simulation package  will be an ideal complement to Elekta Unity. With consistent workflow and image quality from MR simulation through to online MR guidance during radiation treatment, it is designed to exploit the many similarities and synergies between Philips Ingenia MR-RT and Elekta Unity. A common high-field image generation technology enables similar image quality, similar MR console user interfaces, as well as similar coil setup and patient positioning workflows. This helps to enhance reproducibility, accelerate learning curves and drive continuity across the care path.
 Elekta Unity has CE mark but is not available for commercial distribution or sale in the U.S or Canada
 The MR simulation package for Elekta Unity is work in progress and not available for sale or distribution.